Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial [version 4; peer review: 2 approved, 2 approved with reservations]

Introduction Antimalarial therapeutic efficacy studies are routinely conducted in malaria-endemic countries to assess the effectiveness of antimalarial treatment strategies. Targeted amplicon sequencing (AmpSeq) uniquely identifies and quantifies genetically distinct parasites within an infection. I...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Mainga Hamaluba, Juliana Wambua, Arjen M. Dondorp, Jennifer Musyoki, Caroline Ngetsa, Oksana Kharabora, Leonard Ndwiga, Zaydah de Laurent, Kevin Wamae, Kelvin Kimenyi, Gabriel Mwambingu, Peter Kalume, Philip Bejon, Jeffrey Bailey, Rob van der Pluijm, Lynette Ochola-Oyier, Jonathan Juliano, Victor Osoti
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wellcome 2024-03-01
Serier:	Wellcome Open Research
Fag:	Artemisinin-based combination therapy pfama1 Pfmdr1 artemisinin resistance antimalarial resistance targeted deep sequencing eng
Online adgang:	https://wellcomeopenresearch.org/articles/7-95/v4
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!